This is also supported by studies where dexamethasone, most frequently used steroid in GBM patients, has been shown to inhibit the effects of proinflammatory cytokines, VEGF mRNA expression, VEGFR-2 expression, and macrophage infiltration [39, 41, 42]. The gene discussed is VEGFA; the disease is glioblastoma.